Skip to main content

STUDY 7204 GET INVOLVED STUDIES 7204 Clinical Diagnosis of Acute Porphyria


Clinical Diagnosis of Acute Porphyria

In order to participate in a study, you must personally
 contact Edrin @ the APF 1/866/APF/3635

Status: Recruiting

For Diseases:

  • Acute Intermittent Porphyria (AIP)
  • Hereditary Coproporphyria (HCP)
  • Variegate Porphyria (VP)

Background

The porphyrias are a group of genetic diseases caused by disturbances in the formation of heme, an essential component of hemoglobin and other proteins, leading to either acute cutaneous symptoms. Acute porphyria is often difficult to diagnose because the symptoms of abdominal pain, nausea, vomiting, etc. are not specific to porphyria. The purpose of this study is to test whether a focused questionnaire and laboratory evaluation tool can better define risk factors associated with possible genetic porphyria.
The goals of this study are:
  • To determine whether first degree family members of patients with genetically-confirmed acute porphyria have symptoms and laboratory findings.
  • To devise a Genetic Carrier Profile that could be used to screen people in whom the diagnosis of porphyria is being considered.
  • To explain other possible causes of minor increases in porphyrin levels in patients with recurrent abdominal pain who have not been diagnosed with porphyria
This is a longitudinal study will consist of two parts.
Part 1: 100 people.
We will enroll individuals who are first-degree relatives (child, sibling, or parent) of a patient with a genetically-confirmed diagnosis of one of the acute porphyrias (called the index case). We are interested in all three types of acute porphyria: Acute Intermittent Porphyria (AIP), Hereditary Corproporphyria (HCP) or Variegate Porphyria (VP). Participants (the first-degree relatives) must not have had any genetic testing in the past. They will have a study visit during which they will complete a history questionnaire and have routine laboratory tests, including genetic testing for the acute porphyria mutation that is in their family. The researchers will use this data to develop a Clinical Profile of the risk factors associated with being a genetic carrier of acute porphyria.
Part 2: Not Yet Recruiting
Researchers will test the validity of the Clinical Profile. This part of the study will include subjects who are thought to possibly have acute porphyria, but do not have a confirmed.
Participation in Parts 1 and 2 of the study include one study visit with the following:
  • A physical exam
  • Answering questions about your health and quality of life
  • Donation of Giving samples for laboratory evaluations, including samples of blood, urine, and possibly stool
  • Donation of Giving a blood sample for genetic testing
  • Review of your medical records

Targeted Enrollment

To be eligible to participate in Part 1, you must:
  • Be 15 years of age or older
  • Be a first-degree relative (child, sibling, or parent) of an individual with genetically proven acute porphyria (AIP, HCP or VP)
  • Not have had any previous genetic testing for acute porphyria
To be eligible to participate in Part 2, you must:
  • Be 15 years of age or older
  • Have a history of suggestive clinical features, such as abdominal, back or limb pain, recurrent nausea lasting days, reaction to medications, etc.
  • An increase in urinary, fecal or serum porphobilinogen (PBG) and/or porphyrins
In order to participate in a study, you must personally
 contact Edrin @ the APF 1/866/APF/3635

Comments

Popular posts from this blog

GLOBAL PORPHYRIA ALLIANCE

GLOBAL PORPHYRIA ALLIANCE The APF is proud to support our members that live across the globe. Many countries around the world have developed organizations to support their local communities. We hope that enjoy the same opportunity to communicate with one another, develop friendships, and learn about porphyria. Here are links to patient advocacy groups worldwide that offer support to individuals impacted by porphyria. Argentina: Centro de investigaciones sobre porfirinas y porfirias | More informationAustralia: Porphyria Association, Inc. | More informationBrazil: Associação Brasileira de Porfiria | More informationCanada: Canadian Association for Porphyria | More informationColombia: Fundación Colombiana Para La Porfiria | More informationDenmark: Porfyriforeningen.dk (Porphyria Association Denmark)Denmark: Porfyrier.dk (Danish Porphyria Support Group)England: British Porphyria AssociationFinland: Finnish Porphyria Support Group France: Association Française des Malades Atteints de Por…

WHAT IS NEUROPATHIC PAIN?

What could it be?
Nerve Pain WHAT IS NEUROPATHIC PAIN? Neuropathic or nerve pain (NP) is a long-term or chronic pain disease that results from nerve damage. It can be caused by different diseases or conditions. Worldwide nerve pain affects as many as 26 million people. Neuropathic or nerve pain may affect larger areas of the body or it can be restricted to a smaller area, in this case it is called localized neuropathic pain (LNP). WHAT CAUSES NEUROPATHIC PAIN? Neuropathic or nerve pain may occur in the absence of an obvious visible cause (e.g. an accident, an injury, a chemical burn). There are several external situations that can directly damage nerves and lead to neuropathic pain, such as: Amputation of a limb (phantom pain, stump pain)Surgery (scar pain, post-surgery pain)Trauma or accident Neuropathic pain is also a common complication of other diseases, including nerve damage after shingles or herpes zoster infection (postherpetic neuralgia or PHN), nerve damage after HIV infectio…

Happy Winter Season!

                  Happy Winter Season!